Integrated analysis of the potential roles of miRNA-mRNA networks in triple negative breast cancer

Molecular Medicine Reports

Volumn 16, Issue 2, 2017, Pages 1139-1146

  Zhu, Huiru ^a   Dai, Meiyu ^b   Chen, Xiaoli ^b   Chen, Xiang ^b   Qin, Shini ^b   Dai, Shengming ^b  

^a The Third Clinical Faculty of Guangxi University of Chinese Medicine   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Gene ontology analysis; MicroRNA; mRNA; Pathway analysis; Triple negative breast cancer

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 21; MICRORNA 320D 1; MICRORNA 548V; MICRORNA 558; MICRORNA 99A; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; BREAST CARCINOGENESIS; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENETIC ASSOCIATION; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; REPRODUCIBILITY;

CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 85022343067     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2017.6750     Document Type: Article

References (32)

1. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al.: Molecular portraits of human breast tumours. Nature 406: 747-752, 2000.
2. Pierobon M and Frankenfeld CL: Obesity as a risk factor for triple-negative breast cancers: A systematic review and meta-analysis. Breast Cancer Res Treat 137: 307-314, 2013.
3. Foulkes WD, Smith IE and Reis-Filho JS: Triple-negative breast cancer. N Engl J Med 363: 1938-1948, 2010.
4. Lehmann BD, Bauer JA, Chen X, Sanders M.E., Chakravarthy AB, Shyr Y and Pietenpol JA: Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121: 2750-2767, 2011.
5. Blows FM, Driver KE, Schmidt M.K., Broeks A., van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen T.O., Blomqvist C., et al.: Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: A collaborative analysis of data for 10, 159 cases from 12 studies. PLoS Med 7: e000279, 2010.
6. Cui Q, Yu Z, Pan Y., Purisima EO and Wang E MicroRNAs preferentially target the genes with high transcriptional regulation complexity. Biochem Biophys Res Commun 352: 733-738, 2007
7. Kim VN and Nam JW: Genomics of microRNA. Trends Genet 22: 165-173, 2006.
8. Rodriguez A, Griffiths-Jones S, Ashurst JL and Bradley A: Identification of mammalian microRNA host genes and transcription units. Genome Res 14: 1902-1910, 2004.
9. Yang L, Feng Y, Qi P., Xu S and Zhou Y Mechanism of serum miR-21 in the pathogenesis of familial and triple negative breast cancer. J Biol Regul Homeost Agents 30: 1041-1045, 2016.
10. Zhang G, Liu Z, Han Y, Wang X and Yang Z: Overexpression of miR-509 increases apoptosis and inhibits invasion via suppression of tumor necrosis factor-α in triple-negative breast cancer Hs578T cells. Oncol Res 24: 233-238, 2016.
11. Mathe A, Wong-Brown M, Morten B., Forbes JF, Braye SG, Avery-Kiejda KA and Scott RJ: Novel genes associated with lymph node metastasis in triple negative breast cancer. Sci Rep 5: 15832, 2015
12. Agarwal V, Bell GW, Nam JW and Bartel DP: Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, 2015
13. Shannon P, Markiel A, Ozier O., Baliga NS, Wang JT, Ramage D, Amin N., Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504, 2003.
14. Huang da W., Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2009
15. Huang da W., Sherman BT and Lempicki RA: Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13, 2009
16. Sam LT, Mendonca EA, Li J, Blake J., Friedman C and Lussier YA: PhenoGO: An integrated resource for the multiscale mining of clinical and biological data. BMC bioinformatics 10 (Suppl 2): S8, 2009
17. Labi V and Erlacher M: How cell death shapes cancer. Cell Death Dis 6: e1675, 2015
18. Zhang C, Wang S, Israel H.P., Yan SX, Horowitz DP, Crockford S, Gidea-Addeo D, Clifford Chao KS, Kalinsky K and Connolly EP Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy. Springerplus 4: 386, 2015
19. Kim S, Park HS, Kim J.Y., Ryu J., Park S and Kim SI: Comparisons of oncologic outcomes between triple-negative breast cancer (TNBC) and Non-TNBC among patients treated with breast-conserving therapy. Yonsei Med J 57: 1192-1198, 2016.
20. Shi KQ, Lin, Z Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L and Chen YP: Hepatocellular carcinoma associated microRNA expression signature: Integrated bioinformatics analysis, experimental validation and clinical significance. Oncotarget 6: 25093-25108, 2015
21. Dai M, Chen X, Mo S., Li J, Huang Z, Huang S., Xu J, He B, Zou Y., Chen J and Dai S: Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: Integrated bioinformatics analysis, experimental validation and diagnostic evaluation. Sci Rep 7: 46572, 2017
22. An N, Shi X, Zhang Y., Lv N, Feng L, Di X., Han N, Wang G, Cheng S and Zhang K: Discovery of a novel immune gene signature with profound prognostic value in colorectal cancer: A model of cooperativity disorientation created in the process from development to cancer. PloS One 10: e0137171, 2015.
23. Volinia S and Croce CM: Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci USA 110: 7413-7417, 2013.
24. Zhang X, Peng Y, Jin Z., Huang W, Cheng Y, Liu Y., Feng X, Yang M, Huang Y., Zhao Z, et al.: Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma. Oncotarget 6: 32878-32889, 2015.
25. Lovering RC, Camon EB, Blake JA and Diehl AD: Access to immunology through the gene ontology. Immunology 125: 154-160, 2008.
26. Xiong H, Li Q, Liu S., Wang F, Xiong Z, Chen J., Chen H, Yang Y, Tan X., Luo Q, et al.: Integrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinoma. PLoS One 9: e110163, 2014.
27. Li C, Nong Q, Solanki M.K., Liang Q., Xie J, Liu X, Li Y., Wang W, Yang L and Li Y: Differential expression profiles and pathways of genes in sugarcane leaf at elongation stage in response to drought stress. Sci Rep 6: 25698, 2016.
28. Ma G, Luo Y, Zhu H., Luo Y, Korhonen PK, Young N.D., Gasser RB and Zhou R: MicroRNAs of Toxocara canis and their predicted functional roles. Parasit Vectors 9: 229, 2016.
29. Ha M and Kim VN: Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15: 509-524, 2014.
30. Lapkina-Gendler L., Rotem I, Pasmanik-Chor M, Gurwitz D., Sarfstein R, Laron Z and Werner H: Identification of signaling pathways associated with cancer protection in Laron syndrome. Endocr Relat Cancer 23: 399-410, 2016.
31. Shi KQ, Lin Z, Chen X.J., Song M., Wang YQ, Cai YJ, Yang NB, Zheng M.H., Dong JZ, Zhang L and Chen YP: Hepatocellular carcinoma associated microRNA expression signature: Integrated bioinformatics analysis, experimental validation and clinical significance. Oncotarget 6: 25093-25108, 2015.
32. Geraldo MV and Kimura ET: Integrated analysis of thyroid cancer public datasets reveals role of post-transcriptional regulation on tumor progression by targeting of immune system mediators. PLoS One 10: e0141726, 2015.